Orthofix Medical Inc. (OFIX)

Orthofix Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	760.05	746.64	460.71	464.48	406.56	459.96
Revenue Growth (YoY)	43.54%	62.06%	-0.81%	14.25%	-11.61%	1.53%
Cost of Revenue	256.86	260.37	123.54	114.91	101.89	100.61
Gross Profit	503.19	486.27	337.17	349.57	304.67	359.35
Selling, General & Admin	519.48	530.4	308.78	290.67	272.38	309.28
Research & Development	76.42	80.23	49.07	49.62	39.06	34.64
Other Operating Expenses	16.02	14.76	-7.4	17.59	-0.5	34.21
Operating Expenses	611.92	625.38	350.44	357.88	310.94	378.13
Operating Income	-108.73	-139.11	-13.27	-8.32	-6.27	-18.78
Interest Expense / Income	11.9	8.63	1.29	1.84	2.48	0.12
Other Expense / Income	2.89	0.94	3.15	3.34	-8.38	8.14
Pretax Income	-123.52	-148.68	-17.71	-13.5	-0.37	-27.05
Income Tax	2.96	2.72	2.04	24.88	-2.89	1.41
Net Income	-126.48	-151.4	-19.75	-38.38	2.52	-28.46
Shares Outstanding (Basic)	38	37	20	20	19	19
Shares Outstanding (Diluted)	38	37	20	20	19	19
Shares Change	5.62%	83.16%	1.84%	1.54%	2.58%	-0.04%
EPS (Basic)	-3.38	-4.12	-0.98	-1.95	0.13	-1.51
EPS (Diluted)	-3.38	-4.12	-0.98	-1.95	0.13	-1.51
Free Cash Flow	-91.36	-107.8	-34.7	-1.12	57.18	11.51
Free Cash Flow Per Share	-2.42	-2.94	-1.73	-0.06	2.97	0.61
Gross Margin	66.20%	65.13%	73.18%	75.26%	74.94%	78.13%
Operating Margin	-14.31%	-18.63%	-2.88%	-1.79%	-1.54%	-4.08%
Profit Margin	-16.64%	-20.28%	-4.29%	-8.26%	0.62%	-6.19%
Free Cash Flow Margin	-12.02%	-14.44%	-7.53%	-0.24%	14.06%	2.50%
EBITDA	-56.37	-86.99	12.6	17.94	32.66	-2.23
EBITDA Margin	-7.42%	-11.65%	2.74%	3.86%	8.03%	-0.48%
Depreciation & Amortization	55.26	53.06	29.02	29.6	30.55	24.7
EBIT	-111.62	-140.05	-16.42	-11.66	2.12	-26.93
EBIT Margin	-14.69%	-18.76%	-3.56%	-2.51%	0.52%	-5.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).